VANCOUVER, BRITISH COLUMBIA--(Marketwire - May 29, 2008) - Med BioGene Inc. (TSX VENTURE:MBI), a life science company focused on the development and commercialization of genomic-based diagnostic tests for cancer and cardiovascular disease, is pleased to announce that Heiner Dreismann, Ph.D., has joined the company’s Board of Directors and will chair MBI’s Strategy Committee. Dr. Dreismann is the former Chief Executive Officer of Roche Molecular Diagnostics (Roche), a division of F. Hoffmann-La Roche Ltd.
